MS31 is a high-affinity, highly selective, fragment-like methyl-lysine reader protein spindlin1 (SPIN1) inhibitor that effectively disrupts the SPIN1–H3K4me3 protein–protein interaction (IC50 = 77 nM, AlphaLISA; 243 nM, FP); it selectively binds to the Tudor domain II of SPIN1 (Kd = 91 nM) and potently inhibits the binding of trimethyl-lysine-containing peptides to SPIN1, showing no toxicity toward non-cancerous cells.